Two-Drug cocktail shows promise for awakening traumatic brain injury patients
NCT ID NCT06052787
First seen Nov 19, 2025 · Last updated Jun 15, 2026 · Updated 28 times
Summary
This study tested whether adding two drugs—cerebrolysin and amantadine sulfate—to standard care helps people with moderate to severe traumatic brain injury recover in the ICU. 150 adults aged 18-70 took part. Researchers measured consciousness, disability, and recovery over 6 weeks. The goal was to see if the combination improves outcomes more than standard treatment alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Faculty of medicine - Ain shams university
Cairo, Egypt
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.